SCHEMBL13620868

SCHEMBL13620868

COC1OC(C)(C)[C@H](OC)C(O)C1O

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
IDE P14735 1/20 0.34
SYNJ2 O15056 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13609345 1.00 IDE (0.34) IDESYNJ2
SCHEMBL10306469 1.00 IDE (0.34) IDESYNJ2
SCHEMBL10258976 1.00 IDE (0.34) IDESYNJ2
SCHEMBL7884469 1.00 IDE (0.34) IDESYNJ2
SCHEMBL6155838 0.82 GBA1 (0.31)
SCHEMBL6158792 0.82 GBA1 (0.31)
SCHEMBL6155840 0.82 GBA1 (0.31)
SCHEMBL6936524 0.82 GBA1 (0.31)
SCHEMBL14959986 0.81 IDE (0.31) IDE
SCHEMBL7884693 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7622451-B2 Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders UNIVERSITY OF KANSAS (US) 2009-11-24 US disclosed